Stock market review: pharma’s eternal return

This stock market review examines the pharmaceutical sector and its commercial evolution. It highlights the prospect of more favorable sales for pharma groups. The analysis therefore presents the sector as the central theme of the market under review, with particular attention to the expected improvement in its commercial prospects.